President and Chief Executive Officer
Waters Corporation
Milford, Massachusetts
As President and CEO of Waters Corporation, Dr. Udit Batra brings more than two decades of leadership and operational expertise in the healthcare and life sciences industries. He has a proven track record leading multi-billion-dollar global organizations and driving results at the top of the industry.
Before joining Waters in September 2020, Udit served as CEO of the $7.7 billion life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the United States and Canada. In 2015, Udit led the formation of MilliporeSigma, with the largest merger in the life science tools industry at the time. Udit led the team that oversaw a strategic and operational transformation of the business that drove record sales growth and margin development. From 2011-2013, as CEO of Merck KGaA’s consumer health business, Udit led a period which saw doubling of the business’ profitability and achieving organic growth in the top tier of the industry.
Earlier in his career, Udit served in a range of leadership positions at Novartis, a Swiss multinational pharmaceutical company. In addition to leading Corporate Strategy and Global Public Health and Market Access for Vaccines and Diagnostics, he also served as president of the Australia Pharma business. During his tenure, this subsidiary became the fastest-growing business amongst competitors in Australia and in Novartis. Throughout his career, Udit has championed science education, especially for low-income students, developed and promoted women’s leadership, and has been a strong advocate for increasing diversity across the organizations he has led.
Udit has received numerous leadership accolades and recognition, including 2021 Mass Technology Leadership Council’s Tech Top 50, 2020 New Englander of the Year by the New England Council, 2019 New England Choice Awards Business Person of the Year, PharmaVOICE Top 100 Most Inspirational People (2017 - 2019), Boston Business Journal’s 2019 Power 50, and the 2016 CPhl Pharma CEO of the Year.
Currently, Udit is a board member of Massachusetts Biotechnology Council (MassBio); the Massachusetts High Tech Council, of which he is the immediate past Chairman; and the Analytical, Life Science & Diagnostics Association (ALDA). He also serves on the Advisory Councils of the Chemical Engineering Departments of Princeton University where he earned his Ph.D. in Chemical Engineering and the University of Delaware where he earned a B.S. in Chemical Engineering.
Disclosure information not submitted.
Wednesday, October 19, 2022
4:15 PM – 5:30 PM ET